CRISPR THERAPEUTICS

View On IC.GC.CA

REGISTERED

on 7 Jun 2024

Last Applicant/ Owned by

CRISPR THERAPEUTICS AG

Baarerstrasse 14CH-6300 ZUG V8

Serial Number

1999531 filed on 23^rd Oct 2019

Registration Number

TMA1236794 registered on 7^th Jun 2024

Registration expiry Date

9^th Oct 2028

Correspondent Address

SMART & BIGGAR LP

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOTTAWA

ONTARIO

K1P5Y6

CRISPR THERAPEUTICS

Trademark usage description

human cells for medical and clinical use, namely, for the treatment of human diseases in the nature of oncology and rare diseases; pharmaceutical and Read More

Vienna Information

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

26 . 4 . 2

RectanglesRectangles

26 . 4 . 7

Two quadrilaterals, one inside the otherDeux quadrilatères, l'un dans l'autre

26 . 4 . 18

Quadrilaterals containing one or more lettersQuadrilatères contenant une ou plusieurs lettres

26 . 4 . 24

Quadrilaterals with dark surfaces or parts of surfacesQuadrilatères avec surface ou partie de la surface foncée

25 . 5 . 2

Backgrounds divided into two, horizontallyFonds partagés en deux dans le sens horizontal

26 . 4 . 26

Quadrilaterals with cutout areasQuadrilatères avec des zones découpées

Classification Information

Class [005]
Human cells for medical and clinical use, namely, for the treatment of human diseases in the nature of oncology and rare diseases; pharmaceutical and biopharmaceutical agents for the treatment of cancer, autoimmune disorders, and transplant rejections; pharmaceutical and biopharmaceutical preparations and substances for the treatment of cancer, autoimmune disorders, and transplant rejections; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of genetic diseases and disorders.

Classification kind code

Class [041]
Education services, namely, providing online non-downloadable articles and newsletters in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy.

Classification kind code

Class [042]
Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics using gene editing; pharmaceutical, medical, biopharmaceutical, and medical scientific research and development; medical scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals; gene editing.

Classification kind code

Mark Details

Serial Number

1999531

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 22 on 11^th Mar 2021	Search Recorded
Submitted for opposition 20 on 11^th Mar 2021	Examiner's First Report
Submitted for opposition 223 on 11^th Mar 2021	Total Provisional Refusal
Submitted for opposition 256 on 5^th Oct 2020	Notification of Possible Opposition Sent
Submitted for opposition 236 on 17^th Sept 2020	Partial Withdrawal - Madrid Protocol
Submitted for opposition 257 on 5^th Dec 2019	Designation Notification - Madrid Protocol
Submitted for opposition 1 on 4^th Dec 2019	Created
Submitted for opposition 31 on 4^th Dec 2019	Formalized
Submitted for opposition 30 on 23^rd Oct 2019	Filed
Submitted for opposition 228 on 9^th Oct 2018	International Registration